Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Thursday, 9th May 2024 CLLS stock ended at $3.24. This is 4.52% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 10.30% from a day low at $3.01 to a day high of $3.32.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Mar 02, 2022 $4.35 $4.42 $4.11 $4.15 185 100
Mar 01, 2022 $4.42 $4.51 $4.28 $4.33 177 300
Feb 28, 2022 $4.57 $4.66 $4.43 $4.53 275 600
Feb 25, 2022 $4.58 $4.58 $4.32 $4.40 442 000
Feb 24, 2022 $4.10 $4.36 $4.10 $4.29 314 500
Feb 23, 2022 $4.60 $4.62 $4.31 $4.32 417 800
Feb 22, 2022 $4.79 $4.88 $4.64 $4.67 207 700
Feb 18, 2022 $5.26 $5.26 $4.75 $4.76 572 100
Feb 17, 2022 $5.49 $5.55 $5.26 $5.35 149 400
Feb 16, 2022 $5.65 $5.70 $5.51 $5.61 199 600
Feb 15, 2022 $5.69 $5.74 $5.57 $5.60 182 200
Feb 14, 2022 $5.37 $5.47 $5.26 $5.33 156 500
Feb 11, 2022 $5.63 $5.75 $5.24 $5.36 282 200
Feb 10, 2022 $5.63 $5.97 $5.57 $5.64 188 700
Feb 09, 2022 $5.76 $6.01 $5.74 $5.82 266 200
Feb 08, 2022 $5.74 $5.79 $5.59 $5.59 129 300
Feb 07, 2022 $5.82 $6.04 $5.79 $5.81 176 400
Feb 04, 2022 $5.79 $5.89 $5.58 $5.79 251 800
Feb 03, 2022 $5.94 $6.06 $5.81 $5.82 171 400
Feb 02, 2022 $6.38 $6.41 $5.99 $6.03 268 900
Feb 01, 2022 $6.74 $6.74 $6.03 $6.28 825 225
Jan 31, 2022 $6.08 $6.44 $6.07 $6.21 583 900
Jan 28, 2022 $6.03 $6.20 $5.83 $6.00 478 200
Jan 27, 2022 $6.45 $6.50 $6.09 $6.12 153 100
Jan 26, 2022 $6.69 $7.02 $6.39 $6.44 170 200
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT